Close

Warning

You are about to leave ethypharm.com

Regulations vary by country. The information provided on the website you wish to visit may not correspond to that of your country.

Click on CONTINUE if you wish to access the site of one of our subsidiaries.

Continue
Close

Become part of our candidate pool

Join Ethypharm in the future.

You would like to apply but there are no vacancies matching your search. By choosing the unsolicited application form, I can access personalised content that matches my expectations.Fill in tour details and you will be able to join our applicant pool before our advertisments are publiched.It’s up to you!
Ethypharm - About us - At a glance
At a glance

A clear focus on Central Nervous System (CNS) and Hospital Injectables

Ethypharm is a specialty pharmaceutical company providing essential medicines in CNS – specifically for severe pain and addiction, as well as a wide range of injectable medicines for hospitals and emergency situations.

To accelerate our growth, we have identified specific CNS diseases and conditions, critical care situations where our skills and know-how can be leveraged to bring valuable solutions to patients and health care providers.

Our teams and resources are fully focused on making these opportunities happen.

Join our international mission-driven Team!   

We are a multi-disciplinary, international team, composed of various personalities who join through common values and collective thinking.
We are convinced that our diversity and the combination of our talents are our strength.

The Group is led by a management team with a broad range of expertise in the pharmaceutical industry.

An entrepreneurial mindset and shared values unite us in achieving our vision for the Group.

Discover our Management Team
Join our Team

A solid and growing presence in our core geographies

Since 2015, Ethypharm has built its direct commercial presence in Europe and China.

In Europe, Ethypharm is present in the 5 largest markets – Germany, France, Italy, the United Kingdom, and Spain. Direct sales account for 66% of our direct revenues. We are actively working on scaling our presence in these five countries.

In China, Ethypharm is one among the few European specialty pharmaceutical companies to have a longstanding direct presence. This great asset is being leveraged via partnerships.

In the rest of the world, we rely on our network of distributors and licensees to establish and develop the reach of our product portfolio.

Ethypharm key figures (2024)

435M€
Group net sales
of which
39%
in CNS
31%
in Hospital Injectables
29%
in Internal Medicine

6
direct countries.

85%
of direct revenues (pharma sales).

6
manufacturing sites in the UK, France (2) , Spain (2) & in China.

+1800
employees of which 1400 are in industrial operations.